NCT02764086 2026-04-13
INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Cancer Trials Ireland
Phase 1/2 Terminated
Cancer Trials Ireland
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
NYU Langone Health
University of Washington
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Korea Cancer Center Hospital
Eli Lilly and Company
Boneca Corporation